Hot Pursuit     09-Feb-21
AstraZeneca Pharma tumbles after Q3 PAT declines 21% YoY
AstraZeneca Pharma India lost 4.24% to Rs 3734.05 after the company's net profit declined 21.2% to Rs 21.05 crore in Q3 FY21 from Rs 26.7 crore in Q3 FY20.
Net sales for Q3 FY21 stood at Rs 200.25 crore, a 10.5% fall over Rs 223.86 crore recorded in Q3 FY20. The result was announced after market hours yesterday, 8 February 2021.

Profit before tax fell 19.6% to Rs 28.30 crore in Q3 FY21 over Q3 FY20. Tax expense fell 12.1% to Rs 7.74 crore in Q3 FY21 over Q3 FY20.

AstraZeneca Pharma India is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease.

Previous News
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 18-Jul-20   17:12 )
  Volumes spurt at Elgi Equipments Ltd counter
 ( Hot Pursuit - 05-Jul-22   14:30 )
  Astrazeneca Pharma India to table results
 ( Corporate News - 31-Oct-23   14:03 )
  Astrazeneca Pharma India receives Import and Market permission for Osimertinib Tablet
 ( Corporate News - 09-Aug-18   10:47 )
  AstraZeneca India gets govt nod for import & sale of cancer-treating drug Enhertu
 ( Hot Pursuit - 04-May-23   11:28 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 26-Nov-21   11:00 )
  AstraZeneca Pharma India terminates distribution services agreement with Sun Pharma
 ( Corporate News - 28-May-21   12:47 )
  Astrazeneca Pharma India standalone net profit rises 128.60% in the March 2024 quarter
 ( Results - Announcements 28-May-24   07:37 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 08-Aug-19   10:11 )
  Astrazeneca Pharma India reports standalone net profit of Rs 29.09 crore in the December 2018 quarter
 ( Results - Announcements 07-Feb-19   16:06 )
  Astrazeneca Pharma India standalone net profit rises 167.30% in the June 2023 quarter
 ( Results - Announcements 14-Aug-23   14:37 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top